Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with proven HIV-1-infection~* No prior exposition to antiretrovirals~* CD4 cell count between 300 and 500/mm3~* Signed written inform consent~Exclusion Criteria:~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).